[2] Some individuals with genetic or medical disorders (such as preterm infants) cannot make enough carnitine, requiring dietary supplementation
But we want all of our active pharmaceutical ingredients that come into this state to be of high quality, regardless of whether its a weight-loss drug or hormone-replacement therapy or anything else. Continuing innovation As Lilly prepares for the release of its own oral weight-loss drug, orforglipron, the company is looking to ensure it does not experience the same shortages it did in the early days of Mounjaro and Zepbound
doi: 10.1097/CM9.0000000000002060 55 BrownEHeerspinkHJLCuthbertsonDJWildingJPH
Let me put a finer point on this
It comprehensively considers all factors that affect actual cost, including raw material prices, bioavailability, manufacturing yield, and shelf-life retention rate
Any cell line may be affected, but thrombocytopenia seems to be a particular issue